PFE Pfizer Inc - 8-K

Item 5.07 Submission of Matters to a Vote of Security Holders

(a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 23, 2026.

(b) Shareholders voted on the matters set forth below.

1. The nominees for election to the Company’s Board of Directors set forth in Item 1 to the Company’s Proxy Statement filed with the U.S. Securities and Exchange Commission on March 12, 2026 were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following votes:

Nominee

Votes For

Votes Against

Abstentions

Broker non-vote

Ronald E. Blaylock

3,442,653,662

102,600,748

11,374,500

941,392,137

Albert Bourla

3,261,211,737

272,132,573

23,284,563

941,392,137

Mortimer J. Buckley

3,403,974,675

141,036,932

11,617,303

941,392,137

Susan Desmond-Hellmann

3,401,932,807

141,056,147

13,639,956

941,392,137

Joseph J. Echevarria

2,929,511,380

612,413,502

14,702,274

941,392,137

Scott Gottlieb

3,415,886,776

130,394,185

10,343,738

941,392,137

Dan R. Littman

3,383,769,589

161,740,872

11,118,449

941,392,137

Shantanu Narayen

3,313,318,763

231,613,932

11,695,915

941,392,137

Suzanne Nora Johnson

3,272,936,863

273,506,151

10,185,896

941,392,137

James Quincey

3,453,778,741

91,549,236

11,300,933

941,392,137

James C. Smith

3,284,035,682

261,217,699

11,375,529

941,392,137

Cyrus Taraporevala

3,468,177,423

76,665,721

11,785,766

941,392,137

2. The proposal to ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year was approved based upon the following votes:

Votes for approval

4,160,827,231

Votes against

321,979,096

Abstentions

15,214,720

Broker non-votes

n/a

3. The proposal to approve the Pfizer Inc. 2019 Stock Plan, as amended April 2026 was approved based upon the following votes:

Votes for approval

3,227,692,578

Votes against

305,428,376

Abstentions

23,507,956

Broker non-votes

941,392,137

4. The proposal to approve, on an advisory basis, the 2026 compensation of the Company's Named Executive Officers was approved based upon the following votes:

Votes for approval

3,099,249,442

Votes against

423,935,881

Abstentions

33,443,287

Broker non-votes

941,392,137

5. The shareholder proposal to Adopt Adopt An Independent Chair Policy was not approved based upon the following votes:

Votes for approval

1,015,206,372

Votes against

2,509,042,021

Abstentions

32,354,566

Broker non-votes

941,392,137